153) The histologic morphology of this tumor was compatible with a diagnosis of a |
154) No recurrence occurred after the tumor was completely excised. |
155) Pathological examination showed that the tumor was composed of blood vessels with r |
156) Histopathologically, the tumor was composed of epithelial tumor cel |
157) 2 thymoma invading the third rib, and the tumor was considered to be a port-site rec |
158) Based on these findings, the tumor was diagnosed as a cavernous hemangi |
159) The tumor was diagnosed as a stage I type B2 t |
160) Histologically, the tumor was diagnosed to be DCIS in tubular |
161) y was performed, and a huge, elastic hard tumor was found around the bilateral coron |
162) coma after which en-bloc resection of the tumor was performed with administration of |
163) thoracoscopic excision of the mediastinal tumor was performed, and pathological diag |
164) The tumor was removed en bloc via a skin creas |
165) The tumor was removed using thoracoscopic surg |
166) A cardiac tumor was suspected on the basis of comput |
167) of OP-PEG-PLA NPs groups increased in the tumor and decreased in the liver and lung |
168) Patients with solid tumor and early-stage disease had longer p |
169) of 2-fluoro-2-deoxyglucose in the breast tumor and lymph node metastasis. |
170) The %ID/g of tumor and major organs were obtained for a |
171) nt in a way that maximizes control of the tumor and minimizes normal tissue injury. |
172) specific anion transporter (BSAT1) in the tumor and peritumoral area is a key compon |
173) ber alterations of PIK3CA gene in bladder tumor and their correspondent paired norma |
174) ly reduced the metastatic capacity of the tumor and this was associated with a reduc |
175) llular carcinoma (HCC) is a hypervascular tumor, and its vascularity is unique and g |
176) a circumscribed mass suggesting a benign tumor, and mammography (MMG) revealed the |
177) ed tomography showed a middle mediastinal tumor, and she was admitted to hospital fo |
178) Here, using patient tumors and cancer cell lines, we identify |
179) Tumor development in response to the HC di |
180) Tumor development is etiologically associa |
181) the signaling pathways that contribute to tumor development and metastatic progressi |
182) has been found to play distinct roles in tumor development and progression, accordi |
183) inase that is important in many facets of tumor development and progression. |
184) anscription factors are integral to HER2+ tumor development and progression. |
185) ozygous deletion of SIRT1 suppresses skin tumor development but sensitizes the B6 mi |
|